Страна 1 од 227 резултати
BACKGROUND OF THE INVENTION
The present invention comprises the surprising and unexpected discovery that administration of a cytoprotective prostaglandin to a mammal suffering from or particularly susceptible to certain inflammatory diseases of the large intestine provides a useful method for
FIELD OF THE INVENTION
The present invention is related to a pharmaceutical composition based upon a dual release dosage form comprising an adequate pharmaceutical carrier, an extended release non-steroidal anti-inflammatory drug (NSAID) and an immediate release stabilized prostaglandin. The present
FIELD OF THE INVENTION
This invention relates to compounds, processes for their preparation, pharmaceutical compositions containing such compounds and to their use in treating therapeutic conditions, in particular their use in the treatment of conditions mediated by the action of ligands for the FP,
TECHNICAL FIELD
This invention relates generally to pharmaceutical compositions, and more particularly relates to a pharmaceutical composition containing a combination of a nonsteroidal anti-inflammatory drug (NSAID) and a prostaglandin.
BACKGROUND ART
Nonsteroidal anti-inflammatory agents such as
TECHNICAL FIELD
This invention relates generally to pharmaceutical compositions, and more particularly relates to a pharmaceutical composition containing a combination of a nonsteroidal anti-inflammatory drug (NSAID) and a prostaglandin.
BACKGROUND
Nonsteroidal anti-inflammatory agents such as
FIELD OF THE INVENTION
This invention is directed to the use of non-steroidal anti-inflammatory agents, and especially certain non-steroidal cyclooxygenase inhibitors in combination with prostaglandin FP receptor agonists for treating glaucoma and/or ocular hypertension in an individual.
BACKGROUND
FIELD OF THE INVENTION
This invention is directed to the use of non-steroidal anti-inflammatory agents, and especially certain non-steroidal cyclooxygenase inhibitors in combination with FP prostaglandin agonists for treating glaucoma and/or ocular hypertension in an individual.
BACKGROUND OF THE
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to compounds, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, in particular their use in the treatment of conditions mediated by the action of ligands for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to compounds, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, in particular their use in the treatment of conditions mediated by the action of ligands for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to compounds, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, in particular their use in the treatment of conditions mediated by the action of ligands for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to compounds, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, in particular their use in the treatment of conditions mediated by the action of ligands for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to compounds, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, in particular their use in the treatment of conditions mediated by the action of ligands for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to compounds, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, in particular their use in the treatment of conditions mediated by the action of ligands for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to compounds, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, in particular their use in the treatment of conditions mediated by the action of ligands for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to compounds, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, in particular their use in the treatment of conditions mediated by the action of ligands for the